Jun 28, 2017 - The second-leg of the Fed's annual bank stress tests will be released today. The CCAR scores will determine whether the 34 largest U.S. financial institutions can go ahead with their capital distribu
Apr 16, 2018 - Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
May 28, 2017 - Merck recently got the first-ever drug approval that is tumor agnostic.While the approval doesn't cast as wide a net as it may seem at first, it could pay dividends.The impact on clinical oncology cou
May 19, 2017 - Anavex is trying to cure an intractable disease, and its competitors are formidable.Anavex's trials have been too small to attach any efficacy significance.Moreover its data has been inconsistent, she
Aug 03, 2017 - Ziopharm is moving into a pivotal trial for the Ad-RTS-hIL-12 + Veledimex treatment for Glioblastoma ((GBM)).The progression with the Point-of-Care therapy using CD19 specific CAR-T cells continues in
Aug 05, 2016 - Also, May's paltry 11K jobs was more than doubled to 24K, and even June's strong 287K rose another 5000 jobs to 292K.
Mar 27, 2017 - The company announced on March 23, 2017, the acquisition of UK-based private oncology company Agalimmune for $6M in cash and stock.Agalimmune's lead drug candidate AGI-134 boosts the immune system, ki
May 01, 2017 - Roche, the Swiss biotech and lab diagnostics giant, reported a strong but unremarkable Q1 recently.A mainstream stock analytic house, Morningstar, last week rated it as its #1 healthcare stock globall
Apr 24, 2017 - Atara hatching a collaboration with Merck in head and neck cancer immunotherapy.Galmed makes a case for its own NASH drug in Europe.Biosimilar rituximab continues to gain momentum in Europe.
Sep 13, 2017 - Ablynx is preparing for a potential first launch of its lead drug candidate caplacizumab in 1H2018, with phase 3 data readout possibly next month.Ablynx has more than 45 proprietary and partnered prog